Assessing Cost-Effectiveness and Key Value Drivers of Adjuvant Triglyceride Lowering Therapy in Management of Patients With a Rare Genetic Syndrome
Value in Health - United Kingdom
doi 10.1016/j.jval.2017.08.891
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2017
Authors
Publisher
Elsevier BV